Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy
Clinical trial NCT02609828 · COMPLETED
Trial details
- NCT number
- NCT02609828
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-28
- Primary completion
- 2020-09-17
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.